##
##
##
##
##
|||Pres|
|---|---|---|
|Trust Infottnation|||
|Report of the Trustees||2-6|
|Independent
Auditor's|Report to the Trustees|7-8|
|Statement ofFinancial|Activities||
|Balance Sheet||10|
|Notes to the Financial|Statements|11 - 17|
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
||||||FOR THE Y|EAR ENDED|30|APRIL 2|021|||
|---|---|---|---|---|---|---|---|---|---|---|---|
|||||||||||Total|Total|
||||||||Unrestricted||dieted|Fundn|Funds|
|||||||Notes||Funds|Funds|2021|2020|
|Income from:||||||||||||
|Donations
and legacies;||||||||||||
|Donations||||||||104,088|93,502|197,590|208,601|
|Charitable
activities:||||||||||||
|Fund raising events||||||||2,019||2,019|34,373|
|Other trading activities:||||||||||||
|Sale ofprints, cards|and|||sweatshirts||||2,269||2,269|5,686|
|Investments||||||||5,604||5,604|9,127|
|Other income - Government||||grants||||7,423||7,423||
|Total income|||||||~121402||93,502 ~214 904||257 787|
|Expenditure
on:||||||||||||
|Charitable
activities||||||||85,060|100,606|185,666|334,576|
|Raising funds||||||||34,500||34,500|65,409|
|Total expenditure||||||||119,560|100,606 ~220 166||~399985|
|Net income/(expenditure)||before gains||||||||||
|and losses on investments||||||||1,842|(7,104)|(5,262)|(142,198)|
|Realised profits/(losses)|on||investments|||||1,694||1,694|(273)|
|Unrealised
profits/(losses)||on|||investments|||59,556||59,556|(35,215)|
|Net income/expenditure||for|||the year|||63,092|(7,104)|55,988|(177,686)|
|Transfers
between
funds||||||||||||
|Net movement
in funds||||||||63,092|(7,104)|55,988|(177,686)|
|Balances brought
forward||at|||1 May 2020|||188,273|267,930|456,203|6 633,889|
|Balances carried forward|||at 30April 2021|||11&.12|~6|251 365|K 260 826 f|512,191|l 456,203|
##
##
|||||Notes|2021|2020|
|---|---|---|---|---|---|---|
|Fixed Assets|||||||
|Tangible Assets|||||1,470|809|
|Investments|||||456,756|474,606|
||||||458,226|475,415|
|Current Assets|||||||
|Stock|||||2,602|2,903|
|Debtors|||||2,912|7,014|
|Cash at bank|and in|hand|||74,817|23,091|
||||||80,330|33,008|
|Creditors: amounts||falling due within one year||10|26,365|52,220|
|Net current|assets I(liabilities)||||53,965|(19,212)|
|Net Assets|||||512 191|456 203|
|Unrestricted|Funds||||||
||General|fund|||96,496|15,228|
||Designated||funds||154,869|173,045|
||||||251,365|188,273|
|Restricted Funds||||12|260,826|267,930|
||||||512 191|456,203|
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
|Unrestricted|funds are expen|dable
at the discretion oft|he trustees
in furtherance
o|fthe objects|fthe objects|of|the charity.|||
|---|---|---|---|---|---|---|---|---|---|
||||Unrestricted|Restricted|||Total||Total|
||||Funds||Funds||2021||2020|
|2) Direct
Grants for|Charitable
Expenditure
medical research||51,757||67,293||119,050||259,921|
|Costs ofresearch programme
Governance
costs (Note 4)|||25,622
7,681||33,313
-||58,935
7,681||66,143
8,512|
||||f85,060||f100,606||6185,666||f334,576|
|3) Cost of|Generating
Funds||Unrestricted|Restricted|||Total||Total|
||||~Fun s||Fiends||2021||2020|
|Promotion
and fund raising
Cost ofprints, cards and sweatshirts
Overheads
and governance
costs (Note 4)|||9,382
1,066
24,053||||9,382
1,066
24,053||34,789
3,516
27,104|
||||34,500|8|-|f,|34,500|f.|65,409|
##
|The costs ofmanaging
the charity have been apportioned
over the r
time spent on different activities.|elevant
activities, Salaries are apportioned|based on|
|---|---|---|
||2021|2020|
|Direct charitable
expenditure
Cost ofgenerating
funds
Governance
costs - medical research
Governance
costs - fundraising|58,935
22,667
7,681
1,386|66,143
25,440
8,512
1,664|
||90,669|8101,759|
##
##
||||||2021||2020|
|---|---|---|---|---|---|---|---|
|Staff costs||||||||
|Total emoluments|||||80,454|f.|87,098|
|There were no employees||who received emoluments|above f60,000|||||
|6) Tangible Fixed|Assets||||Office|||
||||||E~ui men|||
|Cost||||||||
|At 1 May 2020|||||2,475||2,475|
|Additions|||||1,200|||
|Disposals||||||||
|At 30April 2021|||||3,675||2,475|
|Depreciation||||||||
|At 1 May 2020|||||1,666||1,666|
|Charge for the year|||||539||539|
|On Disposals||||||||
|At 30 April 2021|||||2,205||2,205|
|Net Book Value||||||||
|At 30 April 2021||||f,|1,470|f|270|
|At 30April 2020|||||809|I|809|
|7) Investments||||||||
||||||~202||21)20|
|Market value as at|30 April 2020||||474,606||572,029|
|Additions|||||32,631||33,141|
|Dispose(a|||||(30,020)||(32,205)|
|Revaluation|||||59,556||(35,215)|
|Increase/(decrease)|in cash||||(80,017)||(63,144)|
|Market value as at|30 April 2021||||456,756|E|474,606|
|Historic cost|||||364,817|f.432,133||
##
##
|7) Investments
(cont'd)|7) Investments
(cont'd)|||||
|---|---|---|---|---|---|
|Investments
by market value|||2021||2020|
|Charities Aid UK Equity Income Units Fund
Royal Bank of Scotland Deposit account
Quilter Cheviot Portfolio
Other Bank Deposits accounts||B|171,657
861
152,283
131,954||134,585
861
127,562
211,598|
||||E456,756|L|474,606|
|8) Stock||||||
||||2 21||202|
|Prints|||169||169|
|Branded products
Cards|||2,042
391||2,284
450|
||||2,602|f.|2,903|
|9) Debtors|||2 21||202|
|Gilt aid
Prepayments
and accmed income|||2,912||7,014|
||||2,912|f.|7,014|
|10) Creditors: amounts|falling due within|one year|2021||2020|
|Salaries|||6,014||6,452|
|Other creditors
Accruals and deferred income|||1,045
19,306||45,768|
||||26,365|K|52,220|
##
|charity.|||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|||||||Balance||||||Balance|
||||||I|May 2020|Income|Expenditure|Transfers||30|April 2021|
|General
fund
Designated
for|||medical|research||815,228
f.I73,045|182,652|(119,560)||18,176
(18,176)|I
K|96,496
154,869|
|||||||f188/73|f.182,652|(8119,560)|f|-|f.|251,365|
##
||||||Balance||||Balance|
|---|---|---|---|---|---|---|---|---|---|
||||||01-May-19|Income|Expenditure|Transfers|30-Apr-20|
|General|fund||||6154,939|153,914|(271,516)|(22,109)|815,228|
|Designated||for|medical|research|8150,936|||22,109|$173,045|
||||||f305,875|8153,914|(f271,516)|f.|f188,273|
|Balance|Balance||||Balance|
|---|---|---|---|---|---|
|I|May 2020|Income|Expenditure|Transfers|30 April 2021|
|Medical research|$267,930|93,502|(100,606)||260,826|
|12.1)Restricted Funds - Year ended 30 April 2020||||||
||Balance||||Balance|
|01-May-19||Income|Expenditure|Transfers|30-Apr-20|
|Medical research|$328,014|103,600|(163,684)||$267,930|
|Fund balances as at 30April 2021 are represented|by:|||||
|---|---|---|---|---|---|
|||Unrestricted|Restricted|||
|||Funds|Funds||Total|
|Tangible fixed assets||1,470|||1,470|
|Fixed assetinvestments||195,930|260,826||456,756|
|Net current assets / (liabilities)||53,965|||53,965|
|Total net assets||8251,365|f.260,826|f,|512,191|
|s ofuet assets between Funds -Year ended 30|April 2020|||||
|Fund balances as at 30 April 2020 are represented|by:|||||
|||Unrestricted|Restricted|||
|||Funds|Funds||Total|
|Tangible fixed assets||809|||809|
|Fixed asset investments||206,676|267,930||474,606|
|Net current assets / (liabilities)||(19,212)|||(19,212)|
|Total net assets||f188,273|f267,930||8456,203|
##
##
|Year|end|30|April|2022||294,623|
|---|---|---|---|---|---|---|
|Year|end|30|April|2023||120,086|
|Year|end|30|April|2024||111,217|
|Year|end|30|April|2025||75,530|
|Year|end|30|April|2026||16919|
||||||6|619.476|
##
##
|16)Comparative
State||ent ofFinancial Ac|tivity - Year e|nded|30April|2|020|||
|---|---|---|---|---|---|---|---|---|---|
||||||||||Total|
|||||Unrestricted|||Restricted||Funds|
||||Notes||Funds||Funds||2020|
|Income from:||||||||||
|Donations
and legacies:||||||||||
|Donations|||||105,001||103,600||208,601|
|Charitable
activities:||||||||||
|Fund raising events|||||34,373||||34,373|
|Other trading
activities:||||||||||
|Sale ofprints, cards||and sweatshirts|||5,686||||5,686|
|Investments|||||9,127||||9,127|
|Total income|||||154,187||103,600|~257 787||
|Expenditure
on:||||||||||
|Charitable
activities|||2||170,892||163,684||334,576|
|Raising funds|||3||65,409||||65,409|
|Total expenditure||||~236 301|||163,684|~399985||
|Net income/(expenditure)||before gains||||||||
|and losses on investments|||||82,114|-|60,084|-|142,198|
|Realised profits/(losses)|on investments||||(2'/3)||||(273)|
|Unrealised
profits/(losses)||on investments|||(35215)||||(35,215)|
|Net income/expenditure|tbr the year|||~777602||~60.084||~177686||
|Transfers
between
funds||||||||||
|Net movement
in funds||||~777,602||~60,084||~177.686||
|Balances brought
forward||at I May 2019|||305,875||328,014||633,889|
|Balances carried torward||at 30April 2020|11& 12|f,|188,273|~f. 267 930|||f~456 203|